Search Results - "Burstein, H."

Development of a Machine Learning Model for Predicting Treatment-Related Amenorrhea in Young Women with Breast Cancer.

Authors: Song, Long Edib, Zobaida Aickelin, Uwe et al.

Source: Bioengineering (Basel). Nov2025, Vol. 12 Issue 11, p1171. 17p.

Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India.

Authors: Gandrala, Divya Rajappa, Senthil J. Mallavarapu, Krishnamohan et al.

Source: International Journal of Breast Cancer. 4/20/2026, Vol. 2026, p1-8. 8p.

Hidden risks associated with occupational pesticide exposure in women with breast cancer: High frequency of the Luminal B molecular subtype and occurrence of poor prognostic features.

Authors: Cazagranda, Isabella C. de Almeida, Rafaela Frederico Smaniotto, Lucca L. et al.

Source: PLoS ONE. 2/5/2026, Vol. 21 Issue 2, p1-16. 16p.

Complications, Functional Recovery, and Quality of Life in Breast Cancer Patients Undergoing Axillary Surgery.

Authors: Pellegrino, Monica Ioppolo, Francesco Ranalli, Monia et al.

Source: Breast Journal. 7/8/2026, Vol. 2026, p1-9. 9p.

Efficacy of AC‐T Versus TAC Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Retrospective Analysis.

Authors: Mirzania, Mehrzad Anari, Fatemeh Emami, Seyed Amir Hossein et al.

Source: International Journal of Breast Cancer. 6/19/2026, Vol. 2026, p1-9. 9p.

Acute Skin Toxicities After Ultrahypofractionated Versus Hypofractionated Postoperative Radiotherapy in Patients With Early Breast Cancer—A Single‐Institution Clinical Study.

Authors: Petkovska, Gordana Ratosa, Ivica Trajanovska, Valentina Bojovska et al.

Source: International Journal of Breast Cancer. 5/30/2026, Vol. 2026, p1-8. 8p.

Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a.

Authors: Soran, Atilla Göktepe, Berk Demirors, Berkay et al.

Source: Current Oncology. Oct2025, Vol. 32 Issue 10, p556. 14p.

The Cost of Breast Cancer: Economic and Social Perspective.

Authors: Gąska, Izabela Czerw, Aleksandra Pajewska, Monika et al.

Source: Cancers. Sep2025, Vol. 17 Issue 18, p3012. 14p.

A Cohort Study on Cardiovascular Disease Mortality in Breast Cancer Patients With Different Subtypes.

Authors: Wang, Zhipeng Deng, Lihong Wang, Peng et al.

Source: Breast Journal. 4/18/2026, Vol. 2026, p1-11. 11p.

The Yield of Staging Investigations in Patients with Breast Cancer Planned for Neoadjuvant Chemotherapy.

Authors: Taqi, Kadhim Ursu, Camelia Isherwood, Susan et al.

Source: Current Oncology. Apr2026, Vol. 33 Issue 4, p203. 10p.

Radiotherapy De-Escalation in Younger Patients with Breast Cancer: Are We There Yet?

Authors: Georgakopoulos, Ioannis Ntoumas, Georgios Nikiforos Skarlos, Pantelis et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p639. 15p.

Revolutionizing Huntington's Disease Treatment: Breakthroughs in AAV-Mediated Gene Therapy.

Authors: Gavgani, Pedram Moeini García-Domínguez, Mario

Source: Cells (2073-4409). Oct2025, Vol. 14 Issue 19, p1514. 24p.

Evolution of Potentially Actionable Genomic Alterations in Advanced Prostate Cancer: A Real-World Analysis of Serial Circulating Tumor DNA Testing.

Authors: Muniz, Miguel Tsai, L. Jill Orme, Jacob J. et al.

Source: Cancers. Sep2025, Vol. 17 Issue 18, p3048. 14p.

Assessing the Accuracy and Readability of Large Language Model Guidance for Patients on Breast Cancer Surgery Preparation and Recovery.

Authors: Palmarin, Elena Lando, Stefania Marchet, Alberto et al.

Source: Journal of Clinical Medicine. 8/1/2025, Vol. 14 Issue 15, p5411. 9p.

Bone Health and Endocrine Therapy with Ovarian Function Suppression in Premenopausal Early Breast Cancer: A Real-Life Monocenter Experience with Denosumab.

Authors: Rotondi, Angelachiara Frescura, Valentina Arcuri, Giorgia et al.

Source: Current Oncology. Aug2025, Vol. 32 Issue 8, p421. 14p.

Updating the Role of Carboplatin Added to Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis.

Authors: Taglialatela, Ida Ruffilli, Beatrice Conte, Benedetta et al.

Source: Cancers. Dec2025, Vol. 17 Issue 24, p3961. 17p.

Evaluating the Effectiveness of Neoadjuvant Therapy in Her2-Positive Invasive Breast Cancer: A Comprehensive Analysis of 167 Cases in Romania.

Authors: Pop, Bogdan Popa, Carmen Antone, Nicoleta Zenovia et al.

Source: Cancers. Jul2025, Vol. 17 Issue 14, p2312. 11p.

Case Report: Fatal Pneumocystis jirovecii Infection in an Elderly Man Receiving Adjuvant Paclitaxel and Trastuzumab Therapy for HER2‐Positive Breast Cancer.

Authors: Vercueil, Colin Ouaz, Hamza Schultz, Emilie et al.

Source: Case Reports in Oncological Medicine. 5/13/2025, Vol. 2025, p1-4. 4p.

Patient-driven decisions and perceptions of the 'safest possible choice': insights from patient-provider conversations about how some breast cancer patients choose contralateral prophylactic mastectomy.

Authors: Padamsee, Tasleem J. Phommasathit, Crystal Swinehart-Hord, Paige et al.

Source: Psychology & Health. Jun2025, Vol. 40 Issue 6, p1012-1036.

PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis.

Authors: Zaza, Mohamed Rashed, Mohammed H. Elrefaey, Hesham et al.

Source: Canadian Journal of Physiology & Pharmacology. Jan2024, Vol. 102 Issue 1, p55-68.